chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The second vaccination pinched more than the first one, my arm was sore like it was with the first vaccination, but the following day I noticed a twingeing sensation almost like a zapping electrical shock on the inside of the injection ar m just below my armpit when I move my arm
Vaccine was administrated after the beyond use date after the thawprocess; This spontaneous case was reported by a paramedic and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was administrated after the beyond use date after the thawprocess) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027H21B) for COVID-19 prophylaxis.     It was unknown if patient had chronic or long lasting health conditions. It was unknown if patient had acute illness at the time of vaccination and up to one month before. It was unknown if patient had been diagnosed with or tested positive for COVID-19.     On 28-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 28-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was administrated after the beyond use date after the thawprocess). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was administrated after the beyond use date after the thawprocess) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  There was no patient that had any adverse reactions and no reports of any reactions after the administration of the vaccines.  Treatment medications were not reported.
Headache; achy upper body; sore upper legs; my skin was especially sensitive.; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 21Apr2021 at 13:00 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 31Mar2021 at 13:30 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Apr2021, at 07:00 the patient experienced headache, achy upper body, sore upper legs. The patient experienced upper body all felt sore and his skin was especially sensitive. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event headache, achy upper body, sore upper legs and skin sensitive were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Patient indicates she has experienced chronic stabbing pain in the arm since her time of immunization. She indicates it is not all the time, but when placed in certain positions.
Seizure, lasted 2-3 minutes, full body tremors, flailing of arms and legs, blank stare, unresponsive, heavy breathing, responsive after approximately one hour.
This spontaneous report as received from a nurse refers to a patient of unknown demographics. No concurrent conditions or medical history were provided. On 15-DEC-2014, the patient was vaccinated with an expired dose of MMR II injection (lot # H009781 with expiry date 15-MAY-2014; strength, dose, route of administration unspecified). No concomitant medications were reported. No adverse effect were reported. Additional information has been requested.
30 hours post flu shot, the client developed dizziness with nausea took 1 clonazepam & went to bed. Slept 8 hrs. woke in AM & symptoms worse, with extreme dizziness, nausea, near vomiting. Took 1 PHENERGAN. Symptoms continued thru day took meclizine at bedtime. Woke on 10/6 with resolving symptoms. By midday 10/6, all s/s resolved.
Complained of left deltoid swelling and warm to touch.  Keflex 500mg PO BID X's 7 days prescribed.
Information has been received from a physician concerning a 77 year old female who on 06 Dec 2006 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot 655152/0889F). On 06 Dec 2006 the patient experienced pain in her arm and could not use it for almost a day. Unspecified medical attention was sought. At the time of the report, the patient was recovering. The reporting physician considered the events to be disabling. Additional information has been requested.
No temperature. Given vaccine 7-16-12. Developed skin rash 7-26-12 developed skin rash around left eyes, under right breast, right thigh & vagina. Rash was slightly raised, red & itched. No pain associated with rash except vaginally.
I had body aces and fever for one day and half,  felt better by Friday afternoon. However, my left collar bone area and neck on the left side are swollen it. hurts to the touch, my left arm feels heavy. My neck hurst when I move my head.  I?m worried about the swelling.
This is an initial report of an Adverse Event, received on 26Oct2015, for Protein Sciences FLUBLOK. The female subject, received FLUBLOK Intramuscular on an unknown date. On an unknown date after receiving FLUBLOK, the subject called to ask Are you aware of any side effects with bumps and intense itching 24 hours after receiving the injection and continuing for up to 72 hours? Mainly on legs, arms and spots on face?" At the time of the report, the outcome for the events was unknown. Concomitant medications were not reported. The company's assessment of the causal relationship between bumps and FLUBLOK and intense itching and FLUBLOK is a possible relationship in light of the safety profile information that pruritic rash is an expected event. In summary, this case report does not change the known safety profile of FLUBLOK.
Pt came to clinic requesting a RSV vaccine.  Clinic only has Arexvy in stock.  LPN gave Arexvy.  Pt is pregnant and 36 years old.  Unsure how far along  Pt is with pregnancy.
Day 1 5/01:1-12mm Erythemic papular lesions with halo surrounding lesions over entire body involving 50-60% of skin. Day 2: spreading erythematous papular lesions covering 80% of body and on day 3 spread to 95% of skin and was confluent. Pt had been on Septra for 9 days for UTI and was office called upon first exam. Treated with antihistamine, with no benefit, started prednisone 5/3/04. Most likely drug reaction. Vital signs stable throughout.
First dose = 4/6/21 Second dose = 4/27/21 @ 1039 R Deltoid   @1109 Pt with Itchy Throat & Cough @1125 0.3mg Epi            50 mg benadryl IM             1 puff albuterol @1139 EMS            Ems on scene with vitals SBP 140s            Pt Declined transport via ems            Recovered in theater and on site MD monitored/assess pt             @1300 VS             BP 129/78            HR 69
The next day post vax, the pt experienced pain in both wrists, then in back of neck and ankles.
Morning after 1st shot awoke with sore back and neck. Appeared swollen like inflammatory response to shot as day of shot felt fine. I did go to Physical Therapy that morning for knee but didn't do anything out of the ordinary since had been doing that for weeks.  That night was in so much pain couldn't get into bed. Pain  radiated from back to hip to thigh, and down shin, with no feeling in shin. Muscles very tight and was very odd. Seen by provider the next day and received Toradol shot. That did not provide relief so went to local ER. X-rays revealed pinched nerve. Now maybe that was because of the  inflammatory  response or pure dumb luck. Still in lot pain and will receive cortisone shot next week 10 days after 2nd dose today.  Providers feel not related, but one provider said if my back was inflamed even a simple reaching for glass in cupboard could pinch nerve. I was not going to report but then saw someone posted on (social media) had muscle pain and spasms which sounded like what I had. I believe my inflammatory response to shot drove me to the pinched nerve situation. Been in pain for weeks and had to go to 2nd shot in wheelchair.
condition was from 0.17C to 10.33C for 1 hour and 59 minutes due to transport (human error)/MENQUADFI was not supported by the extended stability information with no reported AE; misuse as per local labelling due to being administered post excursion with no reported adverse event; Initial information received on 04-Aug-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 12 years old male patient who reported condition was from 0.17c to 10.33c for 1 hour and 59 minutes due to transport (human error)/ MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE [MENQUADFI] was not supported by the extended stability information with no reported ae (adverse event) and misuse as per local labelling due to being administered post excursion with no reported adverse event.   The patient's past medical history, medical treatment(s), concomitant medication, vaccination(s) and family history were not provided.   On 03-Aug-2022, the patient received a 0.5ml 1X(once)  dose of suspect MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE (strength, formulation was unknown, lot U7294AA and expiry date: 23-May-2024) via intramuscular route in Left deltoid for Immunization.  On 03-Aug-2022 the patient developed a non-serious event condition was from 0.17c to 10.33c for 1 hour and 59 minutes due to transport (human error)/menquadfi was not supported by the extended stability information with no reported ae (product storage error).  On 03-Aug-2022 the patient developed a non-serious event of misuse as per local labelling due to being administered post excursion with no reported adverse event (poor quality product administered) (latency: same day) following the administration of MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE.  Action taken with MENINGOCOCCAL VACCINE (MENQUADFI) was not applicable.   Outcome: unknown     This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
scratches self raw; pustules; bad rash along back; croissant-sized rash on left buttock; Injection site armpit swelling, it moved down to Patient's right side; itchy; bright red; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE JOINT SWELLING (Injection site armpit swelling, it moved down to Patient's right side), PRURITUS (itchy), ERYTHEMA (bright red), SCRATCH (scratches self raw) and RASH PUSTULAR (pustules) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Feb-2021, the patient experienced INJECTION SITE JOINT SWELLING (Injection site armpit swelling, it moved down to Patient's right side), PRURITUS (itchy) and ERYTHEMA (bright red). On 08-Feb-2021, the patient experienced RASH (croissant-sized rash on left buttock). On an unknown date, the patient experienced SCRATCH (scratches self raw), RASH PUSTULAR (pustules) and RASH (bad rash along back). The patient was treated with CORTISONE (topical) at an unspecified dose and frequency. At the time of the report, INJECTION SITE JOINT SWELLING (Injection site armpit swelling, it moved down to Patient's right side), PRURITUS (itchy), ERYTHEMA (bright red), SCRATCH (scratches self raw), RASH PUSTULAR (pustules), RASH (croissant-sized rash on left buttock) and RASH (bad rash along back) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Feb-2021, SARS-CoV-2 test: (Negative) negative for COVID-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided  Treatment medications includes ice and benadryl
Severe dizziness immediately after injection within 1 minute.   Lasted 3 hours. No regular monthly menstrual cycle.
Body aches, sweating, upset stomach, dizziness, and localized pain to my left arm and left side of my upper body.
Pt denied any allergies. At 5:15 AM, client given IM dose of Hep A in RDT and Hep B in LDT. 45 minutes later, Pt c/o itching on trunk of body. Area assessed. Increased redness with pimple small lesions noted. No redness noted at injection site. No other ss noted. Pt very angry. Refused IM Benadryl, NO TX needed.
Received a half dose booster instead of a 3rd full dose; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (Received a half dose booster instead of a 3rd full dose) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Radiation therapy (For an unknown condition).   On 08-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Feb-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ACCIDENTAL UNDERDOSE (Received a half dose booster instead of a 3rd full dose). At the time of the report, ACCIDENTAL UNDERDOSE (Received a half dose booster instead of a 3rd full dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant use were reported No treatment were reported.  The patient called the vaccination provider to ask if patient got a half dose or full dose and said that patient should have gotten the full dose since the patient was undergoing radiation.
J96.00 ACUTE RESPIRATORY FAILURE 6/10/2022 ACUTE RENAL FAILURE, UNSPECIFIED
COUGHING; CHILLS; FEVER; This spontaneous report received from a patient . The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number was not reported and is requested) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced coughing, chills, and fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, chills and coughing was not reported. This report was non-serious.
Hot spot (literally hot to the touch, palpably different than the rest of my scalp); emanating from scalp/with severe pain lasting less than 30 seconds each episode; Mild strange headache/multiple times in 36 hours; This is a spontaneous report from a contactable other health professional (patient). A 48-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number and expiration was not reported) via an unspecified route of administration on 05Feb2021 at 15:00 as single dose for Covid-19 immunization at Fairgrounds (the patient was not pregnant). Medical history included depression from an unknown date and unknown if ongoing. No known allergies, no other vaccine was administered in four weeks. No covid prior vaccination and no covid tested post vaccination. Concomitant medication(s) included bupropion (medication taken within in two weeks). On unspecified date, the patient experienced mild strange headache (just wanted you to know). It came and went quickly, but multiple times 36 hours, the patient had brief hot spot (literally hot to the touch, palpably different than the rest of my scalp) emanating from scalp - mostly top left but sometimes EOP right- with severe pain lasting less than 30 seconds each episode. No therapeutic measures were taken for any of the event. Outcome of the events was recovered.  Information on the lot/batch number has been requested.
This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Got vaccinated with Moderna booster at age of 5 years) in a 5-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication. On 15-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Nov-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Got vaccinated with Moderna booster at age of 5 years). On 15-Nov-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Got vaccinated with Moderna booster at age of 5 years) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.Patient was supposed to get Pfizer booster but the pharmacist gave Moderna booster on 15-Nov-2021 by accident. Reporter already informed their HCP and no reported side effects as of the call. No treatment medications were provided.
Vaccination was given on a Friday and starting Saturday through Sunday patient began having stabbing sharp electrical pain around right knee. Red area developed to right thigh quad and since gone away after three to four days expect redness, warm and swelling to right knee and that has gone away.
This spontaneous report as received from a medical assistant referring to a patients of unknown age and gender. No information was reported regarding the patients' medical history, concurrent conditions, concomitant medications, drug reactions, and allergies. On an unknown date, unspecified number of patients were vaccinated with improperly stored GARDASIL 9 (lot number: N021475 and expiration date: 31-JAN-2020) and ROTATEQ (lot number: N011648 and expiration date: 01-DEC-2018) (product storage error) for prophylaxis. The vaccines were exposed to temperature of 32 F to 35 Fahrenheit (F), below 32 F and as low as 27 F. Time frame was reported as multiple excursions over a period of 1 month. The call was because of a digital data logger. No adverse events were reported. Follow-up information was received from the medical assistant on 30-JAN-2018 regarding the temperature excursions of the vaccines. On 23rd of an unspecified month in 2017, 16-DEC-2017, 02-JAN-2018, and 03-JAN-2018, the vaccines of GARDASIL 9 were administered to unspecified number of patients. On 09-DEC-2017, the vaccines of GARDASIL 9 were exposed to temperature of 33.90 Fahrenheit for 15 minutes X 8 cycles, 120 minutes. Upon receipt of follow-up information it was determined that this case is now valid because patients identifiers were received. Follow up information has been received from a physician on 21-AUG-2018, referring to a 11 year old patient (gender not provided) who on 23-DEC-2017, was vaccinated with improperly stored dose of of GARDASIL 9 lot number: N021475 and expiration date: 31-JAN-2020, (strength, dose, frequency and route of administration were not provided). The vaccine was exposed to temperature of 32 F to 35 Fahrenheit (F), below 32 F and as low as 27 F. Time frame was reported as multiple excursions over a period of 1 month. The call was because of a digital data logger. No adverse events were reported. Sender's Comments: US-009507513-1801USA008060.
Previously healthy patient left country in 01/03. Developed retrosternal pressure with mild SOB on evening of 4/27/03. The episode lasted approx. 1 hour, and subsided wtihout treatment.  The next a.m. while he was walking to breakfast, the chest pain/pressure and SOB returned and radiated to his jaw and down his left arm.  He also c/o L) arm numbness, generalized weakness, and dizziness while walking.  He was seen on sick call and rated his pain as 8-9/10 on pain scale. No fever, URI or pleuritic pain.  He was treated with NTG, MSO4 with relief. During transfer to the hospital, the pain recurred. He then received thrombolytics for a presumed AMI. His CV exam was normal. Since receiving thrombolytics, there has been no recurrence of chest pain/pressure.  He was medi-evac'd to another country, then to Medical Center, where a cardiac cath was completed. CAD risk factors: 10 pack-year history, (+) Family history of CAD (father, brother with MIs before age 50). Discharged to 2 weeks conval. leave, on Diltiazem 240mg q day. Cardiology f/u on 5/22/03. Discharge diagnosis - Acute coronary syndrome, likely myopericarditis.
Pain severe in joints and muscles starting in hips and spreading to arms , back and sides, made worse by movement. Lasted about5-7 minutes than subsided.
patient presented office 10/16/19 for c/o welt like rash to left thigh where pt received Proquad vaccine. pt denies any pain/itching to area. no changes to pt activity/appetite or sleep. dad states he noticed the rash today. no fever reported. dad just concerned with rash after vaccine and wants to make sure pt is okay.
Pt. received Tdap x 2 in short time frame. No known adverse reactions. Received on 1/23/14 and 2/6/14.
Received Covid Vaccine on 12/23/20 (Wednesday) and only had a sore arm for a few days. On Saturday the 26th started having headaches, from a scale of 1 to 10, the pain is at a 7. The headaches have not gone away and they have been at a 7th the entire time. Been taking Ibuprofen and switched to Tylenol (helped more with the headaches).
A patient received a booster dose from a vial that was opened yesterday (post 12 hours puncture).; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A patient received a booster dose from a vial that was opened yesterday (post 12 hours puncture).) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (A patient received a booster dose from a vial that was opened yesterday (post 12 hours puncture).). On 18-Nov-2021, EXPIRED PRODUCT ADMINISTERED (A patient received a booster dose from a vial that was opened yesterday (post 12 hours puncture).) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment information were reported by the reporter
Pt felt very tired after shot for couple days, she couldn't hardly lift her arms, she feels itchy most of the day and has rash off and on. She uses steroid creams to control the itch. Her symptoms are still bothering her today.